1 |
An R, Li YQ, Lin YL, Xu F, Li MM, Liu Z. EZH1/2 as targets for cancer therapy. Cancer Gene Ther 2023;30:221-35. [PMID: 36369341 DOI: 10.1038/s41417-022-00555-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Zhang J, Xun M, Li C, Chen Y. The O-GlcNAcylation and its promotion to hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer 2022;1877:188806. [PMID: 36152903 DOI: 10.1016/j.bbcan.2022.188806] [Reference Citation Analysis]
|
3 |
Zou Z, Cheng Q, Li Z, Gao W, Sun W, Liu B, Guo Y, Liu J. [microRNA let-7g-3p regulates proliferation, migration, invasion and apoptosis of bladder cancer cells by targeting HMGB2]. Nan Fang Yi Ke Da Xue Xue Bao 2022;42:1335-43. [PMID: 36210706 DOI: 10.12122/j.issn.1673-4254.2022.09.09] [Reference Citation Analysis]
|
4 |
. Corrigendum. J Cell Mol Med 2022;26:3296-302. [PMID: 35668053 DOI: 10.1111/jcmm.17335] [Reference Citation Analysis]
|
5 |
Vaziri A, Wilinski D, Freddolino PL, Ferrario CR, Dus M. A nutriepigenetic pathway links nutrient information to sensory plasticity.. [DOI: 10.1101/2021.12.17.473205] [Reference Citation Analysis]
|
6 |
Spaner DE. O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers. Front Immunol 2021;12:772304. [PMID: 34868034 DOI: 10.3389/fimmu.2021.772304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
You Z, Peng D, Cao Y, Zhu Y, Yin J, Zhang G, Peng X. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization. J Cell Mol Med 2021;25:9168-82. [PMID: 34510715 DOI: 10.1111/jcmm.16792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|